Results 61 to 70 of about 9,852,057 (296)

Development of a Global Health Learning Progression (GHELP) Model

open access: yesPharmacy, 2020
There has been a steady increase in global health experiential opportunities offered within healthcare professional training programs and with this, a need to describe the process for learning.
Ellen M. Schellhase   +5 more
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Erickson Educational Foundation Newsletter, Vol. 07, No. 01 (Spring 1974)

open access: yes, 1974
A newsletter by the Erickson Educational Foundation containing information and resources for and about "transexual" people and "transexualism"
Erickson Educational Foundation
core   +1 more source

The impact of team teaching on cephalometric tracing education among dental students: A quasi-experimental study

open access: yesJournal of Medical Education Development
Background & Objectives: Cephalometric tracing education in orthodontics necessitates a thorough review of human anatomy. Juggling expertise in two fields poses a challenge for professors.
Mostafa Sheikhi, Mahdis Mostajabi
doaj   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Erickson Educational Foundation Newsletter, Vol. 08, No. 01 (Spring 1975)

open access: yes, 1975
A newsletter by the Erickson Educational Foundation containing information and resources for and about "transexual" people and "transexualism"
Erickson Educational Foundation
core   +1 more source

Erickson Educational Foundation Newsletter, Vol. 08, No. 02 (Winter 1975)

open access: yes, 1975
A newsletter by the Erickson Educational Foundation containing information and resources for and about "transexual" people and "transexualism"
Erickson Educational Foundation
core   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Erickson Educational Foundation Newsletter, Vol. 09, No. 01 (Summer 1976)

open access: yes, 1976
A newsletter by the Erickson Educational Foundation containing information and resources for and about "transsexual" people and "transsexualism"
Erickson Educational Foundation
core   +1 more source

Erickson Educational Foundation Newsletter, Vol. 02, No. 01 (Spring 1969)

open access: yes, 1969
A newsletter by the Erickson Educational Foundation containing information and resources for and about "transexual" people and "transexualism"
Erickson Educational Foundation
core   +1 more source

Home - About - Disclaimer - Privacy